Patents expiring in 2032

US 8329845

Divided redox-curing type composition

KURARAY NORITAKE DENTAL INC. · Granted Tue Dec 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8329636

Carcinoma diagnosis and treatment, based on ODC1 genotype

THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, A CALIFORNIA CORPORATION · Granted Tue Dec 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8329662

Prodrug of an ICE inhibitor

Vertex Pharmaceuticals Incorporated · Granted Tue Dec 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8329687

Pyridooxazepine derivative and use thereof

Takeda Pharmaceutical Company Limited · Granted Tue Dec 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8329664

Anti-viral pyrimidine nucleoside derivatives

University College Cardiff Consultants Limited · Granted Tue Dec 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8329696

Solid state forms of sitagliptin salts

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Dec 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8329691

Amide compounds and use of the same

Takeda Pharmaceutical Company Limited · Granted Tue Dec 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8329182

Immunoglobulin chimeric monomer-dimer hybrids

Syntonix Pharmaceuticals, Inc. · Granted Tue Dec 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8329719

Neuroprotective agents for the prevention and treatment of neurodegenerative diseases

Lixte Biotechnology, Inc. · Granted Tue Dec 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8329205

Bioabsorbable composition and coatings of a fatty acid salt, epsilon-caprolactone, a monomer, and homopolymers or copolymers

Covidien LP · Granted Tue Dec 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8329179

Death domain containing receptor 4 antibodies and methods

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Dec 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8329181

Methods for treating B-cell lymphoma by administering an anti-CD20 antibody

REGENERON PHARMACEUTICALS, INC. · Granted Tue Dec 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8329141

Locoregional internal radionuclide ablation of abnormal tissues

The Board of Regents of the University of Texas System · Granted Tue Dec 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8328785

Use of nanoparticles in the photodynamic treatment of tumors

The Board of Regents of the University of Texas System · Granted Tue Dec 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

BR PI0614453

método de redução de cululite indesejada em áreas seletivas de um organismo e mistura fotossensibilizante

CERAMOPTEC IND INC [US] · Granted Tue Dec 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8329873

Bispecific single chain Fv antibody molecules and methods of use thereof

The Regents of the University of California · Granted Tue Dec 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

CA 2838876

COMPOSITIONS ET PROCEDES DE TRAITEMENT, DE SUPPRESSION, DE REDUCTION OU D'AMELIORATION D'UNE DOULEUR INFLAMMATOIRE

BAUSCH & LOMB [US] · Granted Thu Dec 13 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Dec 08 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8334260

sFRP and peptide motifs that interact with sFRP and methods of their use

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Dec 18 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8334259

Method of treating endothelial dysfunction comprising administration of a thrombin peptide derivative

The Board of Regents of the University of Texas System · Granted Tue Dec 18 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8334282

Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes

Jenrin Discovery, LLC · Granted Tue Dec 18 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8334239

High affinity VEGF-receptor antagonists

The Board of Regents of the University of Texas System · Granted Tue Dec 18 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8334273

Compositions and methods for inhibiting expression of factor VII gene

Alnylam Pharmaceuticals, Inc. · Granted Tue Dec 18 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8334373

Nuclease resistant double-stranded ribonucleic acid

Alnylam Pharmaceuticals, Inc. · Granted Tue Dec 18 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8334377

Porphyrin catalysts and methods of use thereof

THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Tue Dec 18 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8333959

Ex-vivo application of solid microparticulate therapeutic agents

Board of Regents of the University of Nebraska by and behalf of the University of Nebraska Medical Center · Granted Tue Dec 18 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8334409

Process for purifying rasagiline base

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Dec 18 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8334313

Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease

PTC THERAPEUTICS, INC. · Granted Tue Dec 18 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8334301

5-Membered heterocyclic compound

Takeda Pharmaceutical Company Limited · Granted Tue Dec 18 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8334296

2,4-pyrimidinediamine compounds and their uses

Rigel Pharmaceuticals, Inc. · Granted Tue Dec 18 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8334297

2,4-pyrimidinediamine compounds for treatment of inflammatory disorders

Rigel Pharmaceuticals, Inc. · Granted Tue Dec 18 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8334272

Methods for nucleic acid transfer into cells

Northwestern University · Granted Tue Dec 18 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8334294

4,8-diphenyl-polyazanaphthalene derivatives

Almirall, S.A. · Granted Tue Dec 18 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8338418

Dual-acting antihypertensive agents

Theravance, Inc. · Granted Tue Dec 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8338461

1-heterocyclylsulfonyl, 3-aminomethyl, 5-(hetero-)aryl substituted 1-H-pyrrole derivatives as acid secretion inhibitors

Takeda Pharmaceutical Company Limited · Granted Tue Dec 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8338545

Multi-arm block copolymers as drug delivery vehicles

Nektar Therapeutics · Granted Tue Dec 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8338622

Heterocyclic compound

Takeda Pharmaceutical Company Limited · Granted Tue Dec 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8338484

N,N-disubstituted aminoalkylbiphenyl antagonists of prostaglandin D2 receptors

Panmira Pharmaceuticals, LLC · Granted Tue Dec 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8338569

FGFR extracellular domain acidic region muteins

Five Prime Therapeutics, Inc. · Granted Tue Dec 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8338597

Pyridones useful as inhibitors of kinases

Vertex Pharmaceuticals Incorporated · Granted Tue Dec 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8338632

Cycloalkylmethylamines

REVIVA PHARMACEUTICALS, INC. · Granted Tue Dec 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8338103

Method of diagnosing poor survival prognosis colon cancer using miR-106a

The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer · Granted Tue Dec 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8337866

Porin B (PorB) as a therapeutic target for prevention and treatment of infection by chlamydia

The Regents of the University of California · Granted Tue Dec 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8337860

Development of dengue virus vaccine components

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Dec 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8337854

Monoclonal antibodies against dengue and other viruses with deletion in Fc region

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8337848

Monoclonal antibody for APP

University College Cardiff Consultants Limited · Granted Tue Dec 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8337853

Monoclonal antibodies that bind or neutralize dengue virus

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8337830

Yeast-based vaccines as immunotherapy

The Regents of the University of Colorado · Granted Tue Dec 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8337832

Vaccine for protection against Shigella sonnei disease

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)